ArticleCancer chemotherapy and pharmacology2024

Exploring the effect of BRCA1/2 status on chemotherapy-induced hematologic toxicity in patients with ovarian cancer.

In Hee Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.